Abstract
Two probands with unknown reasons for low fibrinogen activity were considered to investigate the association between mutations in inherited fibrinogen disorders (IFDs) and clinical features in the Chinese population. A routine coagulation test was conducted on a Sysmex CS5100 coagulation analyzer, and Sanger sequencing was employed to analyze mutations. A PubMed database search through May 2020 was performed to identify relevant studies regarding the congenital fibrinogen disorder epidemic in China. A common heterozygous missense mutation (c.1233G > A p.Arg35His), a novel heterozygous mutation (c.2014T > C p.Trp672Arg), and a novel homozygous mutation (c.16A > G p.Ile6Val) in the FGA gene were identified in two probands with dysfibrinogenemia. The global coagulation screening assay can distinguish four types of IFD, especially a ratio of Fib:Ag/Fib:C equal to 1.5, which can distinguish patients with hypofibrinogenemia from those with hypodysfibrinogenemia. A total of 81 mutations from 76 probands in 45 IFD families have been reported in the Chinese population. Arg35 in FGA and Arg301 in FGG were responsible for IFD in more than half of patients in the Chinese population. It is possible to distinguish four types of IFD by using a global coagulation screening assay. Mutations in FGA, FGB and FGG occur in different functional regions, and Arg changes account for more than 70% of patients with IFD in the Chinese population, especially Arg-Cys, which may be associated with severe clinical symptoms.
References
De Moerloose P, Neerman-Arbez M (2009) Congenital fibrinogen disorders. Seminars in thrombosis and hemostasis. Thieme Medical Publishers, New York, pp 356–366
Lefebvre P, Velasco PT, Dear A, Lounes KC, Lord ST, Brennan SO, Green D, Lorand L (2004) Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AαIVS4 + 1G > T mutation and an AαGln328 truncation (fibrinogen Keokuk). Blood 103(7):2571–2576
Kant JA, Fornace AJ, Saxe D, Simon MI, McBride OW, Crabtree GR (1985) Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 82(8):2344–2348
Hanss M, Biot F (2001) A database for human fibrinogen variants. Ann N Y Acad Sci 936(1):89–90
Bridey F, Négrier C, Duval C, Ariëns R, de Moerloose P, Casini A (2019) Impaired factor XIII activation in patients with congenital afibrinogenemia. Haematologica 104(3):e111–e113. https://doi.org/10.3324/haematol.2018.203901
Le Quellec S, Desjonqueres A, Rugeri L, Clavel HD, Farhat F, Mechtouff L, Dargaud Y (2018) Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency. Thromb J 16(1):6
Sugo T, Endo H, Matsuda M, Ohmori T, Madoiwa S, Mimuro J, Sakata Y (2006) A classification of the fibrin network structures formed from the hereditary dysfibrinogens. J Thromb Haemost 4(8):1738–1746
Flood VH, Al-Mondhiry HA, Farrell DH (2006) The fibrinogen Aα R16C mutation results in fibrinolytic resistance. Br J Haematol 134(2):220–226
Stenson PD, Mort M, Ball EV, Shaw K, Phillips AD, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133(1):1–9
Vitkup D, Sander C, Church GM (2003) The amino-acid mutational spectrum of human genetic disease. Genome Biol 4(11):R72
Willander K, Falk IJ, Chaireti R, Paul E, Hermansson M, Gréen H, Lotfi K, Söderkvist P (2014) Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia. Biomarker Res 2(1):18
Haverkate F, Samama M (1995) Familial dysfibrinogenemia and thrombophilia. Thromb Haemost 73(01):151–161
Acknowledgements
Special thanks give prof.Tan Dandan (tandandan18@163.com) to provide key information about Fib:Ag testing for analysis. We are also grateful for Sangon Biotech (Shanghai) Co., Ltd. to do Sanger sequencing for us.
Funding
The project was supported partly by grants from Yuzhong District Scientific Research Project (Grant No. 20180129), partly by grants from Municipal and University Cooperative Research Project of Nanchong (Grant No. 18SXHZ0475), and partly by grants from Science and Technology Commission Foundation of Chongqing (Grant No. cstc2018jscx-msybX0107).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
The study was approved by Chongqing General Hospital Ethics Committee. Informed consent was obtained from two family individuals included in this study.
Informed consent
Informed consent was obtained from two family individuals included in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wan, Y., Li, T., Zhang, W. et al. Mutations in inherited fibrinogen disorders correlated with clinical features in the Chinese population. J Thromb Thrombolysis 51, 1127–1131 (2021). https://doi.org/10.1007/s11239-020-02283-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-020-02283-5